CY1121152T1 - AN ANALYSIS OF CELL-MEDIATED MEDIUM RESPONSE - Google Patents

AN ANALYSIS OF CELL-MEDIATED MEDIUM RESPONSE

Info

Publication number
CY1121152T1
CY1121152T1 CY20181100751T CY181100751T CY1121152T1 CY 1121152 T1 CY1121152 T1 CY 1121152T1 CY 20181100751 T CY20181100751 T CY 20181100751T CY 181100751 T CY181100751 T CY 181100751T CY 1121152 T1 CY1121152 T1 CY 1121152T1
Authority
CY
Cyprus
Prior art keywords
cell
analysis
mediated
medium response
immune response
Prior art date
Application number
CY20181100751T
Other languages
Greek (el)
Inventor
Jeff Boyle
Ashley KNIGHTS
Carmen MUNIAN
Original Assignee
Cellestis Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/AU2013/001509 external-priority patent/WO2014100853A1/en
Application filed by Cellestis Limited filed Critical Cellestis Limited
Publication of CY1121152T1 publication Critical patent/CY1121152T1/en

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Αυτή η αποκάλυψη σχετίζεται γενικά με το πεδίο των διαγνωστικών αναλύσεων ανοσολογικής βάσης συμπεριλαμβανομένης μιας ανάλυσης για μέτρηση της κυτταρικώς μεσολαβούμενης ικανότητας ανοσοαπόκρισης. Η παρούσα αποκάλυψη διδάσκει της διάγνωση της έκθεσης ενός ατόμου σε ένα αντιγόνο με βάση την κυτταρικώς μεσολαβούμενη ικανότητα ανοσοαπόκρισης με αυξημένη ευαισθησία που επιτυγχάνεται με προσθήκη ενός μη αναγωγικού σακχάρου κατά τη διάρκεια της επώασης του δείγματος με το αντιγόνο.This disclosure relates generally to the field of immunoassay diagnostic assays including an assay to measure cell-mediated immune response capacity. The present invention teaches the diagnosis of an individual's exposure to an antigen based on the cell-mediated hypersensitivity immune response achieved by the addition of a non-reducing sugar during incubation of the sample with the antigen.

CY20181100751T 2012-12-28 2018-07-18 AN ANALYSIS OF CELL-MEDIATED MEDIUM RESPONSE CY1121152T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261746965P 2012-12-28 2012-12-28
EP13167355 2013-05-10
PCT/AU2013/001509 WO2014100853A1 (en) 2012-12-28 2013-12-20 A cell mediated immune response assay
EP13869475.7A EP2939025B1 (en) 2012-12-28 2013-12-20 A cell mediated immune response assay

Publications (1)

Publication Number Publication Date
CY1121152T1 true CY1121152T1 (en) 2020-05-29

Family

ID=71783691

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20181100751T CY1121152T1 (en) 2012-12-28 2018-07-18 AN ANALYSIS OF CELL-MEDIATED MEDIUM RESPONSE

Country Status (5)

Country Link
CY (1) CY1121152T1 (en)
ES (1) ES2813623T3 (en)
HU (1) HUE050539T2 (en)
LT (1) LT3421997T (en)
PT (1) PT3421997T (en)

Also Published As

Publication number Publication date
LT3421997T (en) 2020-08-25
ES2813623T3 (en) 2021-03-24
HUE050539T2 (en) 2020-12-28
PT3421997T (en) 2020-09-10

Similar Documents

Publication Publication Date Title
CY1123265T1 (en) AN ANALYSIS OF CELL-MEDIATED IMMUNE RESPONSE
TR201904386T4 (en) Method for detecting nucleosomes containing nucleotides.
BR112014013082A2 (en) method for detecting nucleosome adducts
BR112013023540A2 (en) antibody, kit and method for determination of amyloid peptides
MX367046B (en) Pathway specific markers for diagnosing irritable bowel syndrome.
EA201600085A1 (en) KIT FOR DETECTION OF SOYO SYNT SYNT0H2 EVENT
BR112013010952A2 (en) NMR systems and methods for rapid detection of analytes
BR112013001752A2 (en) method of detecting disease or condition using phagocytic cells
CY1122360T1 (en) METHOD FOR THE DIAGNOSIS OF NIEMANN-PICK DISEASE
WO2013039477A8 (en) Non-invasive methods of detecting target molecules
BR112018006635A2 (en) methods for diagnosing infectious diseases using adsorption medium
WO2014165536A8 (en) Methods and kits for the diagnosis of influenza
EA201391187A1 (en) METHOD OF DIAGNOSTICS OF MALIGNANT TUMOR AND A SET FOR DIAGNOSTICS BY MEASURING NK-CELL ACTIVITY
WO2015013508A3 (en) Methods for diagnosing and treating immune disease
MX2016001719A (en) Methods and kits for predicting the risk of having a cardiovascular disease or event.
WO2013167727A3 (en) Method for determining arthritis relapse risk
CY1123112T1 (en) DIAGNOSTIC TEST FOR IMMUNOLOGICAL FOOD SENSITIVITY
BR112017027601A2 (en) cross-pit tomography method, system for imaging subsurface formation and method for obtaining information on subsurface formation
EA201691091A1 (en) DIAGNOSTIC REAGENTS FOR IMPROVED IN VIVO OR IN VITRO CELL-MEDIATED IMMUNOLOGICAL DIAGNOSTICS OF TUBERCULOSIS
MX2016009490A (en) Novel assay to detect human periostin.
WO2014177867A3 (en) Differentially expressed biomarkers for alzheimer's disease
Gün et al. Multidetector angio-CT and the use of D-dimer for the diagnosis of acute mesenteric ischemia in geriatric patients
CY1121790T1 (en) METHOD FOR THE DIAGNOSIS OF NIEMANN-PICK DISEASE
CY1121152T1 (en) AN ANALYSIS OF CELL-MEDIATED MEDIUM RESPONSE
WO2013165969A3 (en) Methods and kits for diagnosing heparin-induced thrombocytopenia